Skip to main content
Equibles

Woodline Partners LP

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$68,627,956
+$36,465,168 QoQ
Shares Held
4,785,771
+38.7% QoQ
Ownership
8.06%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#3
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ZVRA ranks #16 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in ZVRA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,627,956 4,785,771
2026-03-31 $32,162,788 3,450,943
2025-12-31 $30,919,562 3,450,844
2025-09-30 $33,058,119 3,476,143
2025-06-30 $40,664,105 4,615,676
2025-03-31 $34,571,031 4,615,625
2024-12-31 $34,524,205 4,139,593
2024-09-30 $28,097,651 4,048,653
2024-06-30 $5,623,156 1,147,583
2024-03-31 $5,855,778 1,009,617